In unadjusted analyses, we found that higher Ang-2 and sTNFR-1 concentrations were associated with a greater risk of developing severe AKI during hospitalization both in COVID-19 and non-COVID-19 populations (Additional file 1: Table S8). This evidence concerns the gene ANGPT2 and COVID-19.